Porta, Francesco
Maiorana, Arianna
Gragnaniello, Vincenza
Procopio, Elena
Gasperini, Serena
Taurisano, Roberta
Spada, Marco
Dionisi-Vici, Carlo
Burlina, Alberto
Article History
Received: 8 January 2024
Accepted: 26 September 2024
First Online: 7 October 2024
Declarations
:
: Ethics approval for this study was obtained from the ethics committee of AOU Citta della Salute e della Scienza di Torino, Italy (0069665–109/2023). Written consent to participate in this study was obtained from all study participants or their legal guardians. We confirm that all methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not applicable.
: VG received honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from Sanofi and Nutricia; and financial support for attending meetings and/or travel expenses from Sanofi, Nutricia, Amicus and PIAM. SG, EP, FP, AM, CD-V and AB received fees for participation on the advisory board following personal experience in using triheptanoin. MS declares they have no competing interests.